Effect of benztropine on the diurnal prolactin responses to haloperidol
- PMID: 3889966
- DOI: 10.1016/0306-4530(85)90040-x
Effect of benztropine on the diurnal prolactin responses to haloperidol
Abstract
Prolactin (PRL) responses to haloperidol were investigated at 0900 and 1800 h in six young healthy men under basal conditions and after benztropine mesylate administration. Haloperidol administration induced significantly higher PRL release during the evening compared to the morning. The anticholinergic drug, benztropine, potentiated the PRL responses to haloperidol both in the morning and in the evening. The possible mechanisms of these findings are discussed.
Similar articles
-
The effect of benztropine mesylate on the prolactin response to haloperidol.Psychopharmacology (Berl). 1980;72(1):61-5. doi: 10.1007/BF00433807. Psychopharmacology (Berl). 1980. PMID: 6781007
-
Effect of benztropine on haloperidol-induced prolactin secretion.Neuropsychobiology. 1979;5(6):327-31. doi: 10.1159/000117699. Neuropsychobiology. 1979. PMID: 503307
-
Effects of benztropine mesylate on haloperidol-induced prolactin secretion and serum haloperidol levels in rats.J Pharm Sci. 1984 Dec;73(12):1833-5. doi: 10.1002/jps.2600731247. J Pharm Sci. 1984. PMID: 6527272
-
Tuberoinfundibular dopamine neurons and the regulation of prolactin secretion.Psychoneuroendocrinology. 1981;6(1):3-16. doi: 10.1016/0306-4530(81)90044-5. Psychoneuroendocrinology. 1981. PMID: 7017786 Review. No abstract available.
-
Benztropine.2017 Jul 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Jul 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643727 Free Books & Documents. Review.
Cited by
-
Interaction study between remoxipride and biperiden.Psychopharmacology (Berl). 1993;111(1):27-32. doi: 10.1007/BF02257403. Psychopharmacology (Berl). 1993. PMID: 7870930 Clinical Trial.